Google Search
Search
Already a Member ?
Start Lovastatin Production Business(from Dextrose, Peptone Powder, Sugar & Soyabean) | |
| Lovastatin is a medicine that helps to prevent strokes and heart attacks by lowering harmful cholesterol and lipids. Lovastatin is a statin medicine that reduces the risk of heart attack and stroke by lowering bad cholesterol and fats like LDL and triglycerides while retaining good cholesterol in the blood. Lovastatin is a methoxylated carbobicyclic framework fatty acid ester of mevastatin. It's an anticholesteremic medication found in fungus species including Aspergillus terreus and Pleurotus ostreatus (oyster mushroom). Lovastatin is an anti-hypercholesterolemic medication that decreases blood cholesterol levels. Lovastatin inhibits the enzyme 3-hydroxy-3-methylglutaryl coenzyme A reductase, which lowers cholesterol synthesis. As a secondary metabolite, lovastatin is produced commercially by several filamentous fungi, notably Aspergillus terreus. Chemical synthesis is more expensive than fermentation-based lovastatin manufacturing. Lovastatin has recently been identified as a possible therapeutic drug for a number of tumours, as well as for influencing the inflammatory and immunological response, coagulation, bone turnover, neovascularization, vascular tone, and arterial pressure. In people who have or are at risk of developing heart disease, lovastatin is taken in conjunction with diet, weight loss, and exercise to lower the risk of heart attack and stroke, as well as the necessity for heart surgery. Lovastatin is also used to lower blood levels of cholesterol (a fat-like molecule) and other fatty compounds. HMG CoA reductase inhibitors, such as lovastatin, are a class of drug that prevents HMG CoA reductase from working (statins). It works by reducing the amount of cholesterol that can build up on the walls of arteries and obstruct blood flow to the heart, brain, and other vital organs by decreasing cholesterol production in the body. Biomedical Applications of Lovastatin Coronary heart disease (CHD) is a type of heart disease that affects the arteries that provide blood to the heart (CHD) Because of their well-known efficacy and safety profile, statins are the drug of choice for the treatment of hypercholesterolemia, and they can also have antiatherosclerotic effects in addition to their hypolipidemic activity. Inhibiting HMG-CoA reductase has pleiotropic effects because lovastatin metabolism produces a range of isoprenoids that are important for a variety of cellular processes, from cholesterol production to cell proliferation and differentiation regulation. Actions to Lower Cholesterol Statins function by blocking an enzyme involved in cholesterol synthesis, which occurs primarily in the liver. In the presence of the enzyme HMG CoA reductase, 3-hydroxy-3-methyglutaryl coenzyme A is converted to mevalonate, a precursor of cholesterol. Lovastatin is a hydrophobic ring structure covalently bonded to a substrate analogue that inhibits cholesterol synthesis by binding to the reductase enzyme. Statins operate by preventing cholesterol synthesis from reaching its rate-limiting stage. Alzheimer's disease medications (AD) In patients with hypercholesterolemia, lovastatin has been shown to lessen the risk of Alzheimer's disease. Many of the recognised risk factors for Alzheimer's disease have been linked to cholesterol metabolism. Higher doses of lovastatin, a cholesterol biosynthesis inhibitor that prevents the creation of mevalonate, appear to slow the progression of Alzheimer's disease. Renal disease is treated with lovastatin. Patients with increasing renal illness have profited from the significant breakthroughs. HMG-CoA reductase inhibitors may protect against glomerulonephritis, a kidney condition marked by inflammation and/or increased epithelial cell proliferation. Cholesterol-Lowering Drugs on a Global Scale The market is expected to rise between 2021 and 2026, owing to the growing geriatric population. The rise of the cholesterol-lowering medicine market is predicted to be fueled by the introduction of new pharmaceutical classes, changes in lifestyles, a lack of exercise, and an increase in saturated and trans-fat intake. Furthermore, increased smoking and alcohol consumption increases the risk of high cholesterol, which propels market expansion. Between 2015 and 2020, the global Lovastatin market grew at a moderate rate. Between 2021 and 2026, the market is estimated to increase at a CAGR of 3.5 percent. Cancer and Lovastatin Inhibition of Ras farnesylation by lovastatin is linked to decreased proliferation and migration in primary cultures of human glioblastoma cells. As a result, lovastatin stopped cancer cells from multiplying. Lovastatin is a medication that is used to treat bone fragments. One of the most recent trends is the usage of lovastatin to treat bone fractures. Lovastatin improves bone production in vitro and in vivo, as well as biomechanical strength of murine long bones with healing fractures, whether administered in large doses or via extended infusions. Due to rising demand for statin drugs, the worldwide Cholesterol Lowering Medications Market is estimated to rise during the forecast period. Based on medicine class, the cholesterol-lowering pharmaceuticals sector is classified into statins and combinations, as well as others. Because of its improved effectiveness and lower costs, this pharmaceutical class is likely to dominate during the projection period. A major portion of the market is expected to come from the Asia Pacific region. This is due to a growth in healthcare knowledge, research, and government activities in the healthcare industry, all of which are contributing to the creation of jobs in the region. Industry Major Market Players • AstraZeneca • Pfizer Inc. • Novartis AG • AbbVie Inc. • Sun Pharmaceuticals Industries Ltd. • Sanofi • Merck & Co. • Amgen Inc. • Dr. Reddy’s • Abbott Laboratories, • GlaxoSmithKline, • Novartis | |
| Plant capacity: 240 MT Per Annum | Plant & machinery: 12 Cr |
| Working capital: - | T.C.I: Cost of Project: 27 Cr |
| Return: 27.00% | Break even: 43.00% |
Email Us |
 Add to Inquiry Basket | |
We can provide you detailed project reports on the following topics. Please select the projects of your interests.
Each detailed project reports cover all the aspects of business, from analysing the market, confirming availability of various necessities such as plant & machinery, raw materials to forecasting the financial requirements. The scope of the report includes assessing market potential, negotiating with collaborators, investment decision making, corporate diversification planning etc. in a very planned manner by formulating detailed manufacturing techniques and forecasting financial aspects by estimating the cost of raw material, formulating the cash flow statement, projecting the balance sheet etc.
We also offer self-contained Pre-Investment and Pre-Feasibility Studies, Market Surveys and Studies, Preparation of Techno-Economic Feasibility Reports, Identification and Selection of Plant and Machinery, Manufacturing Process and or Equipment required, General Guidance, Technical and Commercial Counseling for setting up new industrial projects on the following topics.
Many of the engineers, project consultant & industrial consultancy firms in India and worldwide use our project reports as one of the input in doing their analysis.
Information- One Lac / Lakh / Lakhs is equivalent to one hundred thousand (100,000)
- One Crore is equivalent to ten million (10,000,000)
- T.C.I is Total Capital Investment
- We can modify the project capacity and project cost as per your requirement.
- We can also prepare project report on any subject as per your requirement.
- Caution: The project's cost, capacity and return are subject to change without any notice. Future projects may have different values of project cost, capacity or return.
About NIIR PROJECT CONSULTANCY SERVICES | Hide  |
NIIR PROJECT CONSULTANCY SERVICES (NPCS) is a reliable name in the industrial world for offering integrated technical consultancy services. NPCS is manned by engineers, planners, specialists, financial experts, economic analysts and design specialists with extensive experience in the related industries.
Our various services are: Detailed Project Report, Business Plan for Manufacturing Plant, Start-up Ideas, Business Ideas for Entrepreneurs, Start up Business Opportunities, entrepreneurship projects, Successful Business Plan, Industry Trends, Market Research, Manufacturing Process, Machinery, Raw Materials, project report, Cost and Revenue, Pre-feasibility study for Profitable Manufacturing Business, Project Identification, Project Feasibility and Market Study, Identification of Profitable Industrial Project Opportunities, Business Opportunities, Investment Opportunities for Most Profitable Business in India, Manufacturing Business Ideas, Preparation of Project Profile, Pre-Investment and Pre-Feasibility Study, Market Research Study, Preparation of Techno-Economic Feasibility Report, Identification and Selection of Plant, Process, Equipment, General Guidance, Startup Help, Technical and Commercial Counseling for setting up new industrial project and Most Profitable Small Scale Business.
NPCS also publishes varies process technology, technical, reference, self employment and startup books, directory, business and industry database, bankable detailed project report, market research report on various industries, small scale industry and profit making business. Besides being used by manufacturers, industrialists and entrepreneurs, our publications are also used by professionals including project engineers, information services bureau, consultants and project consultancy firms as one of the input in their research.
Copyright © 2003-2021 NPCS.
